Telomere length and TERT polymorphisms as biomarkers in asbestos-related diseases

1. Toyokuni S. Commentary on “mechanisms of asbestos-induced carcinogenesis” published in 2009. Nagoya J Med Sci 2023; 85: 13–5. doi: 10.18999/nagjms.85.1.13 ToyokuniS Commentary on “mechanisms of asbestos-induced carcinogenesis” published in 2009 Nagoya J Med Sci 2023 85 13 5 10.18999/nagjms.85.1.13 Open DOISearch in Google Scholar

2. Hajj GNM, Cavarson CH, Pinto CAL, Venturi G, Navarro JR, de Lima VCC.. Malignant pleural mesothelioma: an update. J Bras Pneumol 2021; 47: e20210129. doi: 10.36416/1806-3756/e20210129 HajjGNM CavarsonCH PintoCAL VenturiG NavarroJR de LimaVCC Malignant pleural mesothelioma: an update J Bras Pneumol 2021 47 e20210129 10.36416/1806-3756/e20210129 Open DOISearch in Google Scholar

3. Brims F. Epidemiology and clinical aspects of malignant pleural mesothelioma. Cancers 2021; 13: 4194. doi: 10.3390/cancers13164194. BrimsF Epidemiology and clinical aspects of malignant pleural mesothelioma Cancers 2021 13 4194 10.3390/cancers13164194 Open DOISearch in Google Scholar

4. Gaudino G, Xue J, Yang H. How asbestos and other fibers cause mesothelioma. Transl Lung Cancer Res 2020; 9(Suppl 1): S39–46. doi: 10.21037/tlcr.2020.02.01 GaudinoG XueJ YangH How asbestos and other fibers cause mesothelioma Transl Lung Cancer Res 2020 9 Suppl 1 S39 46 10.21037/tlcr.2020.02.01 Open DOISearch in Google Scholar

5. Tallet A, Nault JC, Renier A Hysi I, Galateau-Sallé F, A Cazes A, et al. Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma. Oncogene 2014; 33: 3748–52. doi: 10.1038/onc.2013.351 TalletA NaultJC RenierA HysiI Galateau-SalléF A CazesA Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma Oncogene 2014 33 3748 52 10.1038/onc.2013.351 Open DOISearch in Google Scholar

6. Rossiello F, Jurk D, Passos JF, di Fagagna FA. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol 2022; 24: 135–47. doi: 10.1038/s41556-022-00842-x RossielloF JurkD PassosJF di FagagnaFA Telomere dysfunction in ageing and age-related diseases Nat Cell Biol 2022 24 135 47 10.1038/s41556-022-00842-x Open DOISearch in Google Scholar

7. Lin J, Epel E. Stress and telomere shortening: insights from cellular mechanisms. Ageing Res Rev 2022; 73: 101507. doi: 10.1016/j.arr.2021.101507 LinJ EpelE Stress and telomere shortening: insights from cellular mechanisms Ageing Res Rev 2022 73 101507 10.1016/j.arr.2021.101507 Open DOISearch in Google Scholar

8. Wadowski B, De Rienzo A, Bueno R. The molecular basis of malignant pleural mesothelioma. Thorac Surg Clin 2020; 30: 383–93. doi: 10.1016/j.thorsurg.2020.08.005 WadowskiB De RienzoA BuenoR The molecular basis of malignant pleural mesothelioma Thorac Surg Clin 2020 30 383 93 10.1016/j.thorsurg.2020.08.005 Open DOISearch in Google Scholar

9. Berry TA, Belluso E, Vigliaturo R, Gieré R, Emmett EA, Testa JR, et al. Asbestos and other hazardous fibrous minerals: potential exposure pathways and associated health risks. Int J Environ Res Public Health 2022; 19: 4031. doi: 10.3390/ijerph19074031 BerryTA BellusoE VigliaturoR GieréR EmmettEA TestaJR Asbestos and other hazardous fibrous minerals: potential exposure pathways and associated health risks Int J Environ Res Public Health 2022 19 4031 10.3390/ijerph19074031 Open DOISearch in Google Scholar

10. Pouliquen DL, Kopecka J. Malignant mesothelioma. Cancers 2021; 13: 3447. doi: 10.3390/cancers13143447 PouliquenDL KopeckaJ Malignant mesothelioma Cancers 2021 13 3447 10.3390/cancers13143447 Open DOISearch in Google Scholar

11. Zhu W, Liu J, Li Y, Shi Z, Wei S. Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades. SSM Popul Health 2023; 23: 101441. doi: 10.1016/j.ssmph.2023.101441 ZhuW LiuJ LiY ShiZ WeiS Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades SSM Popul Health 2023 23 101441 10.1016/j.ssmph.2023.101441 Open DOISearch in Google Scholar

12. Cancer in Slovenia 2018. Annual report. Zadnik V, Gašljević G, Hočevar M, Jarm K, Pompe-Kirn V, Strojan P, et al, editors. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Slovenian Cancer Registry; 2020. Cancer in Slovenia 2018 Annual report. ZadnikV GašljevićG HočevarM JarmK Pompe-KirnV StrojanP editors. Ljubljana Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Slovenian Cancer Registry 2020 Search in Google Scholar

13. Štrbac, D, Dolžan V. Novel and future treatment options in mesothelioma: a systematic review. Int J Mo Sci 2022; 23: 1975. doi: 10.3390/ijms23041975 ŠtrbacD DolžanV Novel and future treatment options in mesothelioma: a systematic review Int J Mo Sci 2022 23 1975 10.3390/ijms23041975 Open DOISearch in Google Scholar

14. Guo X, Lin L, Zhu J. Immunotherapy vs. chemotherapy in subsequent treatment of malignant pleural mesothelioma: which is better? J Clin Med 2023; 12: 2531. doi:10.3390/jcm12072531 GuoX LinL ZhuJ Immunotherapy vs. chemotherapy in subsequent treatment of malignant pleural mesothelioma: which is better? J Clin Med 2023 12 2531 10.3390/jcm12072531 Open DOISearch in Google Scholar

15. Okamoto K, Seimiya H. Revisiting telomere shortening in cancer. Cells 2019; 8: 107. doi: 10.3390/cells8020107 OkamotoK SeimiyaH Revisiting telomere shortening in cancer Cells 2019 8 107 10.3390/cells8020107 Open DOISearch in Google Scholar

16. Razgonova MP, Zakharenko AM, Golokhvast KS, Thanasoula M, Sarandi E, Nikolouzakis K, et al. Telomerase and telomeres in aging theory and chronographic aging theory (review). Mol Med Rep 2020; 22: 1679–94. doi: 10.3892/mmr.2020.11274 RazgonovaMP ZakharenkoAM GolokhvastKS ThanasoulaM SarandiE NikolouzakisK Telomerase and telomeres in aging theory and chronographic aging theory (review) Mol Med Rep 2020 22 1679 94 10.3892/mmr.2020.11274 Open DOISearch in Google Scholar

17. Rampazzo E, Cecchin E, Del Bianco P, Menin C, Spolverato G, Giunco S, et al. Genetic variants of the TERT gene. telomere length, and circulating TERT as prognostic markers in rectal cancer patients. Cancers 2020; 12: 3115. doi: 10.3390/cancers12113115 RampazzoE CecchinE Del BiancoP MeninC SpolveratoG GiuncoS Genetic variants of the TERT gene. telomere length, and circulating TERT as prognostic markers in rectal cancer patients Cancers 2020 12 3115 10.3390/cancers12113115 Open DOISearch in Google Scholar

18. Yuan X, Dai M, Xu D. Telomere-related markers for cancer. Curr Top Med Chem 2020; 20: 410–32. doi: 10.2174/1568026620666200106145340 YuanX DaiM XuD Telomere-related markers for cancer Curr Top Med Chem 2020 20 410 32 10.2174/1568026620666200106145340 Open DOISearch in Google Scholar

19. Levstek T, Redenšek S, Trošt M, Dolžan V, Trebušak Podkrajšek K. Assessment of the telomere length and its effect on the symptomatology of parkinson’s disease. Antioxidants 2021; 10: 137. doi: 10.3390/antiox10010137 LevstekT RedenšekS TroštM DolžanV Trebušak PodkrajšekK Assessment of the telomere length and its effect on the symptomatology of parkinson’s disease Antioxidants 2021 10 137 10.3390/antiox10010137 Open DOISearch in Google Scholar

20. Borges G, Criqui M, Harrington L. Tieing together loose ends: telomere instability in cancer and aging. Mol Oncol 2022; 16: 3380–96. doi: 10.3390/antiox10010137 BorgesG CriquiM HarringtonL Tieing together loose ends: telomere instability in cancer and aging Mol Oncol 2022 16 3380 96 10.3390/antiox10010137 Open DOISearch in Google Scholar

21. Cigan SS, Meredith JJ, Kelley AC, Yang T, Langer EK, Hooten AJ, et al. Predicted leukocyte telomere length and risk of germ cell tumours. Br J Cancer 2022; 127: 301–12. doi: 10.1038/s41416-022-01798-3 CiganSS MeredithJJ KelleyAC YangT LangerEK HootenAJ Predicted leukocyte telomere length and risk of germ cell tumours Br J Cancer 2022 127 301 12 10.1038/s41416-022-01798-3 Open DOISearch in Google Scholar

22. Au AY, Hackl T, Yeager TR, Cohen SB, Pass HI, Harris CC, et al. Telomerase activity in pleural malignant mesotheliomas. Lung Cancer 2011; 73: 283–8. doi: 10.1016/j.lungcan.2010.12.023 AuAY HacklT YeagerTR CohenSB PassHI HarrisCC Telomerase activity in pleural malignant mesotheliomas Lung Cancer 2011 73 283 8 10.1016/j.lungcan.2010.12.023 Open DOISearch in Google Scholar

23. Aida S, Aida J, Naoi M, Kato M, Tsuura Y, Natsume I, et al. Measurement of telomere length in cells from pleural effusion: asbestos exposure causes telomere shortening in pleural mesothelial cells. Pathol Int 2018; 68: 503–8. doi: 10.1111/pin.12710 AidaS AidaJ NaoiM KatoM TsuuraY NatsumeI Measurement of telomere length in cells from pleural effusion: asbestos exposure causes telomere shortening in pleural mesothelial cells Pathol Int 2018 68 503 8 10.1111/pin.12710 Open DOISearch in Google Scholar

24. Alfudhili KM, Lynch DA, Laurent F, Ferretti GR, Dunet V, Beigelman-Aubry C. et al. Focal pleural thickening mimicking pleural plaques on chest computed tomography: tips and tricks. Br J Radiol 2016; 89: 20150792. doi: 10.1259/bjr.20150792 AlfudhiliKM LynchDA LaurentF FerrettiGR DunetV Beigelman-AubryC Focal pleural thickening mimicking pleural plaques on chest computed tomography: tips and tricks Br J Radiol 2016 89 20150792 10.1259/bjr.20150792 Open DOISearch in Google Scholar

25. Kim Y, Myong JP, Lee JK, Kim JS, Kim YK, Jung SH, et al. CT characteristics of pleural plaques related to occupational or environmental asbestos exposure from South Korean asbestos mines. Korean J Radiol 2015; 16: 1142–52. doi: 10.3348/kjr.2015.16.5.1142 KimY MyongJP LeeJK KimJS KimYK JungSH CT characteristics of pleural plaques related to occupational or environmental asbestos exposure from South Korean asbestos mines Korean J Radiol 2015 16 1142 52 10.3348/kjr.2015.16.5.1142 Open DOISearch in Google Scholar

26. Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health 2015; 41: 5–15. doi: 10.5271/sjweh.3462 WolffH VehmasT OksaP RantanenJ VainioH Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations Scand J Work Environ Health 2015 41 5 15 10.5271/sjweh.3462 Open DOISearch in Google Scholar

27. Chapel DB, Schulte JJ, Husain AN, Krausz T. Application of immunohistochemistry in diagnosis and management of malignant mesothelioma. Transl Lung Cancer Res 2020; 9(Suppl 1): S3–27. doi: 10.21037/tlcr.2019.11.29 ChapelDB SchulteJJ HusainAN KrauszT Application of immunohistochemistry in diagnosis and management of malignant mesothelioma Transl Lung Cancer Res 2020 9 Suppl 1 S3 27 10.21037/tlcr.2019.11.29 Open DOISearch in Google Scholar

28. Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg 2009; 1: 38–48. doi: 10.4240/wjgs.v1.i1.38 Munkholm-LarsenS CaoCQ YanTD Malignant peritoneal mesothelioma World J Gastrointest Surg 2009 1 38 48 10.4240/wjgs.v1.i1.38 Open DOISearch in Google Scholar

29. Berzenji L, Van Schil PE, Carp L. The eighth TNM classification for malignant pleural mesothelioma. Transl Lung Cancer Res 2018; 7: 543–9. doi: 10.21037/tlcr.2018.07.05 BerzenjiL Van SchilPE CarpL The eighth TNM classification for malignant pleural mesothelioma Transl Lung Cancer Res 2018 7 543 9 10.21037/tlcr.2018.07.05 Open DOISearch in Google Scholar

30. Franko A, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases. J Med Biochem 2020; 39: 91–9. doi: 10.2478/jomb-2019-0025 FrankoA GoricarK KovacV Dodic-FikfakM DolzanV NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases J Med Biochem 2020 39 91 9 10.2478/jomb-2019-0025 Open DOISearch in Google Scholar

31. Klebe S, Leigh J, Henderson DW, Nurminen M. Asbestos. smoking and lung cancer: an update. Int J Environ Res Public Health 2019; 17: 258. doi: 10.3390/ijerph17010258 KlebeS LeighJ HendersonDW NurminenM Asbestos. smoking and lung cancer: an update Int J Environ Res Public Health 2019 17 258 10.3390/ijerph17010258 Open DOISearch in Google Scholar

32. Levstek T, Redenšek S, Trošt M, Dolžan V, Trebušak Podkrajšek K. Assessment of the telomere length and its effect on the symptomatology of Parkinson’s disease. Antioxidants 2021; 10: 137. doi: 10.3390/antiox10010137. LevstekT RedenšekS TroštM DolžanV Trebušak PodkrajšekK Assessment of the telomere length and its effect on the symptomatology of Parkinson’s disease Antioxidants 2021 10 137 10.3390/antiox10010137 Open DOISearch in Google Scholar

33. Lulkiewicz M, Bajsert J, Kopczynski P, Barczak W, Rubis B. Telomere length: how the length makes a difference. Mol Biol Rep 2020; 47: 7181–8. doi: 10.1007/s11033-020-05551-y LulkiewiczM BajsertJ KopczynskiP BarczakW RubisB Telomere length: how the length makes a difference Mol Biol Rep 2020 47 7181 8 10.1007/s11033-020-05551-y Open DOISearch in Google Scholar

34. Havas A, Yin S, Adams PD. The role of aging in cancer. Mol Oncol 2022; 16: 3213–9. doi: 10.1002/1878-0261.13302 HavasA YinS AdamsPD The role of aging in cancer Mol Oncol 2022 16 3213 9 10.1002/1878-0261.13302 Open DOISearch in Google Scholar

35. Kusamura S, Baratti D, De Simone M, Pasqual EM, Ansaloni L, Marrelli D, et al. Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma. Cancers 2023; 15: 662. doi: 10.3390/cancers15030662 KusamuraS BarattiD De SimoneM PasqualEM AnsaloniL MarrelliD Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma Cancers 2023 15 662 10.3390/cancers15030662 Open DOISearch in Google Scholar

36. Zhou M, Jiang B, Xiong M, Zhu X. Association between TERT rs2736098 polymorphisms and cancer risk-a meta-analysis. Front Physiol 2018; 9: 377. doi: 10.3389/fphys.2018.00377 ZhouM JiangB XiongM ZhuX Association between TERT rs2736098 polymorphisms and cancer risk-a meta-analysis Front Physiol 2018 9 377 10.3389/fphys.2018.00377 Open DOISearch in Google Scholar

37. Wang M, Sun Y. Telomerase reverse transcriptase rs2736098 polymorphism is associated with lung cancer: a meta-analysis. J Int Med Res 2020; 48: 300060520936173. doi: 10.1177/0300060520936173 WangM SunY Telomerase reverse transcriptase rs2736098 polymorphism is associated with lung cancer: a meta-analysis J Int Med Res 2020 48 300060520936173 10.1177/0300060520936173 Open DOISearch in Google Scholar

38. Holesova Z, Krasnicanova L, Saade R, Pös O, Budis J, Gazdarica J, et al. Telomere length changes in cancer: insights on carcinogenesis and potential for non-invasive diagnostic strategies. Genes 2023; 14: 715. doi: 10.3390/genes14030715 HolesovaZ KrasnicanovaL SaadeR PösO BudisJ GazdaricaJ Telomere length changes in cancer: insights on carcinogenesis and potential for non-invasive diagnostic strategies Genes 2023 14 715 10.3390/genes14030715 Open DOISearch in Google Scholar

39. Arimura-Omori M, Kiyohara C, Yanagihara T, Yamamoto Y, Ogata-Suetsugu S, Harada E, et al. Association between telomere-related polymorphisms and the risk of IPF and COPD as a precursor lesion of lung cancer: findings from the Fukuoka tobacco-related lung disease (FOLD) registry. Asian Pac J Cancer Prev 2020; 21: 667–73. doi: 10.31557/APJCP.2020.21.3.667 Arimura-OmoriM KiyoharaC YanagiharaT YamamotoY Ogata-SuetsuguS HaradaE Association between telomere-related polymorphisms and the risk of IPF and COPD as a precursor lesion of lung cancer: findings from the Fukuoka tobacco-related lung disease (FOLD) registry Asian Pac J Cancer Prev 2020 21 667 73 10.31557/APJCP.2020.21.3.667 Open DOISearch in Google Scholar

40. Cornean CI, Catana A, Maniu AA, Do polymorphisms of the TERT, GSTM1, and GSTT1 genes increase laryngeal cancer susceptibility in smokers of Romanian descent? Medicina (Kaunas) 2022; 58: 1106. doi: 10.3390/medicina5808110 CorneanCI CatanaA ManiuAA Do polymorphisms of the TERT, GSTM1, and GSTT1 genes increase laryngeal cancer susceptibility in smokers of Romanian descent? Medicina (Kaunas) 2022 58 1106 10.3390/medicina5808110 Open DOISearch in Google Scholar

41. He G, Song T, Zhang Y, Chen X, W, Chen H, et al. TERT rs10069690 polymorphism and cancers risk: a meta-analysis. Mol Genet Genomic Med 2019; 7: e00903. doi: 10.1002/mgg3.903 HeG SongT ZhangY ChenX W ChenH TERT rs10069690 polymorphism and cancers risk: a meta-analysis Mol Genet Genomic Med 2019 7 e00903 10.1002/mgg3.903 Open DOISearch in Google Scholar

42. Benitez-Buelga C, Sanchez-Barroso L, Gallardo M, Apellániz-Ruiz M, Inglada-Pérez L, Yanowski K, et al. Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients. Breast Cancer Res Treat 2015; 149: 385–94. doi: 10.1007/s10549-014-3246-6 Benitez-BuelgaC Sanchez-BarrosoL GallardoM Apellániz-RuizM Inglada-PérezL YanowskiK Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients Breast Cancer Res Treat 2015 149 385 94 10.1007/s10549-014-3246-6 Open DOISearch in Google Scholar

43. Zins K, Peka E, Miedl H, Ecker S, Abraham D, Schreiber M. Association of the telomerase reverse transcriptase rs10069690 polymorphism with the risk, age at onset and prognosis of triple negative breast cancer. Int J Mol Sci 2023; 24: 1825. doi: 10.3390/ijms24031825 ZinsK PekaE MiedlH EckerS AbrahamD SchreiberM Association of the telomerase reverse transcriptase rs10069690 polymorphism with the risk, age at onset and prognosis of triple negative breast cancer Int J Mol Sci 2023 24 1825 10.3390/ijms24031825 Open DOISearch in Google Scholar

44. Schneider CV, Schneider KM, Teumer A, Rudolph KL, Hartmann D, Rader DJ, et al. Association of telomere length with risk of disease and mortality. JAMA Intern Med 2022; 182: 291–300. doi: 10.1001/jamainternmed.2021.7804 SchneiderCV SchneiderKM TeumerA RudolphKL HartmannD RaderDJ Association of telomere length with risk of disease and mortality JAMA Intern Med 2022 182 291 300 10.1001/jamainternmed.2021.7804 Open DOISearch in Google Scholar

45. Hamada T, Yuan C, Bao Y, Mingfeng Zhang, Natalia Khalaf, Ana Babic, et al. Prediagnostic leukocyte telomere length and pancreatic cancer survival. Cancer Epidemiol Biomarkers Prev 2019; 28: 1868–75. doi: 10.1158/1055-9965.EPI-19-0577 HamadaT YuanC BaoY ZhangMingfeng KhalafNatalia BabicAna Prediagnostic leukocyte telomere length and pancreatic cancer survival Cancer Epidemiol Biomarkers Prev 2019 28 1868 75 10.1158/1055-9965.EPI-19-0577 Open DOISearch in Google Scholar

46. Ma R, Liu C, Lu M, Yuan X, Cheng G, Kong F, et al. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma. Urol Oncol 2019; 37: 301.e1–10. doi: 10.1016/j.urolonc.2019.01.014 MaR LiuC LuM YuanX ChengG KongF The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma Urol Oncol 2019 37 301.e1 10 10.1016/j.urolonc.2019.01.014 Open DOISearch in Google Scholar

47. Pandith AA, Wani ZA, Qasim I, Afroze D, Manzoor U, Amin I, et al. Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases. J Gene Med 2020; 22: e3260. doi: 10.1002/jgm.3260 PandithAA WaniZA QasimI AfrozeD ManzoorU AminI Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases J Gene Med 2020 22 e3260 10.1002/jgm.3260 Open DOISearch in Google Scholar

48. Nie X, Shang J, Wang W. TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma. Front Surg 2022; 9: 1019180. doi: 10.3389/fsurg.2022.1019180 NieX ShangJ WangW TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma Front Surg 2022 9 1019180 10.3389/fsurg.2022.1019180 Open DOISearch in Google Scholar